Skip to main content
A Singapore Government Agency Website How to identify
Official website links end with .gov.sg
Government agencies communicate via .gov.sg websites (e.g. go.gov.sg/open). Trusted websites
Secure websites use HTTPS
Look for a lock () or https:// as an added precaution. Share sensitive information only on official, secure websites.

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Health Sciences Authority

Submit a Clinical Research Materials notification

Understand the application process and required documents for your Clinical Research Material notification.

Last updated 30 April 2026

If you are an importer of Clinical Research Material (CRM), you will need to submit a CRM notification before importing the CRM, unless the CRM is locally-registered and you are the licensed importer for the locally-registered product.

If you are a local manufacturer who will be supplying self-manufactured CRM for use in local clinical research, you will need to submit CRM notification before supplying the CRM, unless the CRM is locally-registered and you are the manufacturer and the supplier of the locally-registered product.

There are no fees involved for the CRM notification.

For clinical trials requiring CTA/CTN/CTC

If CRM notification is required, the local sponsor will submit the CRM notification on behalf of the importer or local manufacturer, along with the clinical trial application. “Local sponsor” refers to the local company or local institution which takes responsibility for the initiation, management or financing of the clinical trial. Refer to Conducting clinical trials: Sponsor for more information on sponsor responsibilities.

The CRM notification is submitted in accordance with the steps below:

  • Local sponsor drafts application for Clinical Trial Authorisation/ Notification/ Certificate (CTA/CTN/CTC), which includes a section for CRM notification.

  • Local sponsor notifies the CRM importer or local manufacturer to endorse the CRM notification section in CTA/CTN/CTC application draft.

  • CRM importer or local manufacturer endorses CRM notification section in CTA/CTN/CTC application draft.

  • Local sponsor submits CTA/CTN/CTC application to us.

Note: The quantity of CRM to be imported or supplied should be provided based on the actual or a realistic estimate of the quantity required for the trial protocol and the defined sample size.

Upon successful submission of the CTA/CTN/CTC application, the CRM importer or local manufacturer and local sponsor will receive an email acknowledgement from us. Upon receipt of this acknowledgement, the CRM importer or local manufacturer may proceed to import or supply the CRM respectively.

The CRM notification will remain valid for the duration of the clinical trial.

Refer to CTA, CTN or CTC submissions for details.

For clinical trials not requiring CTA/CTN/CTC, such as medical device trials

If CRM notification is required, the CRM importer or local manufacturer will submit the CRM notification in accordance with the steps below:

  • CRM importer or local manufacturer makes a CRM notification application draft.

  • CRM importer or local manufacturer notifies the local sponsor to endorse the application draft.

  • Local sponsor endorses CRM notification application draft.

  • CRM importer or local manufacturer submits CRM notification to us.

Note:

  • The quantity of CRM to be imported or supplied should be provided based on the actual or a realistic estimate of the quantity required for the research protocol and the defined sample size.

  • “Local sponsor” refers to the local company or local institution which takes responsibility for the initiation, management or financing of the clinical trial.

Upon successful submission of the CRM notification, the CRM importer or local manufacturer and local sponsor will receive an email acknowledgement from us. Upon receipt of this acknowledgement, the CRM importer or local manufacturer may proceed to import or supply the CRM respectively.

The CRM notification will remain valid for one year from the date of notification, and may be extended or amended through PRISM. The CRM importer or local manufacturer must ensure that the CRM notification remains valid when the CRM is being imported or supplied for the clinical research study.

The CRM importer or local manufacturer may cancel the CRM notification if the CRM is eventually not imported or supplied.

Please refer to our Guidance on CRM [PDF, 718 KB] for more details.

Documents required

You will need the following documents before submitting a CRM notification, if applicable:

  • List of components in a medical device system

  • Packing list for study-visit specific lab kits, if products in lab kits are not declared in the application form

How to submit a CRM notification

You will need to submit your CRM notification through PRISM (view sample online form [DOC, 295 KB]). Refer to our training slides on CRM notification [PDF, 2.1 MB] for more details.

Ensure you have the following credentials before you access the e-service:

If you encounter technical issues, e-mail the HSA helpdesk or call 6776 0168 (from 7.00 am to midnight daily).

You may amend, extend or cancel your CRM notification through PRISM. 

To report CRM notification related non-compliances, please submit a CRM Non-Compliance Form.

For submission of CRM notification for clinical trials requiring CTA/CTN/CTC, please refer to CTA, CTN or CTC submissions for details.